Medpace Voice

Medpace Through the Years

This year, Medpace marks its 25th year as a scientifically-driven, global full-service clinical research organization. A lot has changed in the past 25 years. What hasn’t changed is Medpace’s dedication to the mission of accelerating the global development of safe and effective medical therapeutics. In this post, we visually show how we’ve grown from a small group of dedicated people looking for a better way to conduct clinical research to a publicly held, global community of 2,500 employees across 35 countries.

Read More

How to Leverage Research Networks to Accelerate Orphan Drug Development

In this post, Dr. Terence Eagleton highlights the growing interest in the development of products in the rare disease space, the unique challenges involved, and strategies for leveraging rare disease research networks to accelerate drug development.

Read More

Shortened Timelines for Regulatory Review by ANMAT Make Argentina an Excellent Choice for Clinical Research

Author: Wanda Dobrzanski M.D, Head of Clinical Operations Latin America, Medpace

On April 26th, The Ministry of Health in Argentina (ANMAT) issued a new regulation that significantly reduces the timelines for the approval of clinical trials. In this post, I discuss the key changes and the advantages this offers Sponsors who are looking to conduct clinical trials in Latin America.

Read More